Joint Formulary & PAD

Escitalopram - Post-traumatic stress disorder (PTSD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Oral drops
  • Oro-dispersible tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

For use where ordinary tablets are not suitable.

PAD Profile

ChemicalSubstance :
Escitalopram
Indication :
Post-traumatic stress disorder (PTSD)
Group Name :
Keywords :
antidepressants, Selective serotonin re-uptake inhibitors, SSRIs
Brand Names Include :
Cipralex
Important Information :

Off-label use.

Initiation, stabilisation and review by the Mental Health specialist team for a minimum of 1 month before any request is made to transfer prescribing to primary care.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee has agreed to change the length of time that the specialist mental health team should prescribe citalopram, escitalopram, sertraline, fluoxetine and paroxetine for the treatment of PTSD before making a request to primary care.

BLUE (with specialist team initiation). A request for transfer of care to primary care can be made after monitoring for treatment efficacy has been completed, the patient is on the optimal treatment dose and has been stable, defined such that symptoms are not interfering with daily life for at least 1 month.

Other Indications

Below are listed other indications that Escitalopram is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Post-traumatic stress disorder (PTSD).